Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Masiuk M et al. | 2008 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells), K-562 (chronic myelogenous leukemia) | magnetic field, 50/60 Hz | 10–20 mT |
| Falone S et al. | 2008 | animal, rat/Sprague-Dawley, whole body | magnetic field, 50/60 Hz | 0.1 mT |
| Benfante R et al. | 2008 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, signals/pulses, 50/60 Hz, power transmission line | 1–2 mT |
| Delle Monache S et al. | 2008 | intact cell/cell culture, human vein endothelial cells (HUVEC) | magnetic field, low frequency, 50/60 Hz | 1 mT |
| Vianale G et al. | 2008 | intact cell/cell culture, HaCaT cells (human keratinocytes) | magnetic field, 50/60 Hz | 1 mT |
| Schmidt-Rohlfing B et al. | 2008 | intact cell/cell culture, chondrocytes (from human articular cartilage of osteoarthritic knee joints) | magnetic field, low frequency, signals/pulses, 50/60 Hz, electrotherapy | 2 mT |
| Girgert R et al. | 2008 | intact cell/cell culture, MCF-7 (breast cancer cell line, p40 and p181 clone) | magnetic field, low frequency, 50/60 Hz | 1.2 µT |
| Kanitz MH et al. | 2007 | intact cell/cell culture, SF767 (human glioma cell line) | magnetic field, 50/60 Hz, electrotherapy, therapeutic/medical device | 1.2 µT |
| Henderson B et al. | 2006 | intact cell/cell culture, human umbilical venous endothelial cells | magnetic field, 50/60 Hz | 10–700 µT |
| Lupke M et al. | 2006 | intact cell/cell culture, human umbilical cord blood-derived monocytes | magnetic field, 50/60 Hz | 1 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
